
Management Change30 March 2026 at 11:31 am
Asston Pharmaceuticals Announces New Appointments: Sumit Pawar as CFO, Yashvardhan Tupe as Additional Non-Executive Director, and Sandip Sharma as Additional Non-Executive Independent Director
AI Summary
Asston Pharmaceuticals Ltd has announced new appointments in its management team. Mr. Sumit Pawar has been appointed as the Chief Financial Officer, Mr. Yashvardhan Tupe as Additional Non-Executive Director, and Mr. Sandip Sharma as Additional Non-Executive Independent Director. The appointments were approved at the Board of Directors meeting held on 30th March, 2026. The company also announced the date of the Extraordinary General Meeting, scheduled to be held on 28th April, 2026.
Key Highlights
- Mr. Sumit Pawar appointed as Chief Financial Officer
- Mr. Yashvardhan Tupe appointed as Additional Non-Executive Director
- Mr. Sandip Sharma appointed as Additional Non-Executive Independent Director
- Extraordinary General Meeting scheduled for 28th April, 2026
- Appointments approved at the Board of Directors meeting held on 30th March, 2026
APLPharmaceuticals
Asston Pharmaceuticals LtdPrice Impact